MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-12-2026
Aethlon Medical ROE Ratio 2011-2026 | AEMD
Annual ROE Ratio Aethlon Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -261.31 | -211.71 | -79.86 | -60.8 | -83.63 | -68.7 | -269.44 | -94.14 | -1222.03 | -324.31 | -1043.5 | 90.68 | 53.5 | 87.26 | 95.58 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 95.58 | -1222.03 | -226.16 |
Quarterly ROE Ratio Aethlon Medical
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -147.9 | -158.32 | -179.07 | -116.64 | -162.17 | -167.23 | -150.0 | -99.98 | -116.48 | -87.43 | -77.19 | -55.13 | -67.42 | -63.21 | -73.0 | -49.73 | -70.84 | -79.67 | -91.76 | -73.72 | -88.71 | -88.43 | -596.87 | -734.22 | -804.44 | -844.75 | -344.03 | -221.83 | -162.48 | -127.2 | -1276.14 | -1010.73 | -2628.62 | -4220.64 | 5242.88 | 5636.1 | 5591.83 | 7165.45 | -1193.27 | -184.62 | -312.02 | -395.15 | -129.33 | 167.52 | 188.16 | 336.2 | 214.25 | 113.01 | 108.72 | 83.79 | 57.93 | 49.87 | 59.28 | 72.98 | 104.9 | 111.75 | 9.41 | 57.01 | 45.33 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 7165.45 | -4220.64 | 135.02 |
ROE Ratio of other stocks in the Medical devices industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioSig Technologies
BSGM
|
669.04 | - | 37.08 % | $ 85.7 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-19.79 | - | - | $ 1.77 B | USA |
 |
Beyond Air
XAIR
|
-343.26 | $ 0.72 | 3.86 % | $ 48.7 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
-10.47 | - | - | $ 3.31 B | USA |
 |
Lianluo Smart Limited
LLIT
|
-115.26 | - | 24.59 % | $ 44.8 M |  China |
 |
Dynatronics Corporation
DYNT
|
-334.18 | - | 14.99 % | $ 929 K | USA |
 |
Aziyo Biologics
AZYO
|
192.9 | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
9290.44 | - | -26.83 % | $ 2.62 M | USA |
 |
Xtant Medical Holdings
XTNT
|
-38.29 | $ 0.54 | -4.43 % | $ 72.2 M | USA |
 |
Zimmer Biomet Holdings
ZBH
|
7.25 | $ 88.29 | -0.97 % | $ 17.9 B | USA |
 |
Allied Healthcare Products
AHPI
|
-36.97 | - | 3.58 % | $ 2.21 M | USA |
 |
Align Technology
ALGN
|
10.94 | $ 165.93 | -6.43 % | $ 12.4 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-264.39 | - | -5.86 % | $ 30.6 M | USA |
 |
Alphatec Holdings
ATEC
|
-1153.69 | $ 10.9 | -5.43 % | $ 1.64 B | USA |
 |
Conformis
CFMS
|
-93.16 | - | - | $ 16.4 M | USA |
 |
Accuray Incorporated
ARAY
|
-1.96 | $ 0.39 | 4.51 % | $ 40.1 M | USA |
 |
Abbott Laboratories
ABT
|
12.51 | $ 104.33 | -0.23 % | $ 182 B | USA |
 |
Cardiovascular Systems
CSII
|
-14.8 | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
-169.16 | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
-122.23 | - | - | $ 475 M | USA |
 |
Boston Scientific Corporation
BSX
|
11.93 | $ 69.42 | -1.07 % | $ 103 B | USA |
 |
Avinger
AVGR
|
295.39 | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
-5.07 | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
-910.25 | - | 1.15 % | $ 34.5 M | USA |
 |
CONMED Corporation
CNMD
|
4.55 | $ 34.68 | -5.35 % | $ 1.08 B | USA |
 |
Soliton, Inc.
SOLY
|
-46.94 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-0.13 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-25.4 | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
-590.91 | - | - | $ 1.08 M | USA |
 |
Misonix, Inc.
MSON
|
-11.88 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-1451.06 | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
-107.92 | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-186.54 | $ 0.6 | -0.18 % | $ 32.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
10.38 | $ 79.45 | -3.23 % | $ 46.5 B | USA |
 |
BIOLASE
BIOL
|
8353.04 | - | -13.19 % | $ 166 K | USA |
 |
AdaptHealth Corp.
AHCO
|
-4.66 | $ 11.11 | -2.63 % | $ 1.5 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-11.44 | $ 15.65 | -4.31 % | $ 367 M | USA |
 |
Invacare Corporation
IVC
|
-25.37 | - | - | $ 24.7 M | USA |
 |
Ra Medical Systems
RMED
|
-290.12 | - | 10.0 % | $ 610 K | USA |
 |
Myomo
MYO
|
-136.57 | $ 0.67 | -1.26 % | $ 28 M | USA |
 |
Penumbra
PEN
|
12.45 | $ 335.28 | -0.34 % | $ 13 B | USA |
 |
Inspire Medical Systems
INSP
|
18.62 | $ 49.77 | -1.35 % | $ 1.46 B | USA |
 |
Pulmonx Corporation
LUNG
|
-99.79 | $ 1.17 | -5.65 % | $ 47.6 M | USA |
 |
Cutera
CUTR
|
33.31 | - | -10.19 % | $ 1.99 M | USA |
 |
Eargo
EAR
|
-156.15 | - | - | $ 10.2 M | USA |
 |
NuVasive
NUVA
|
4.65 | - | - | $ 2.07 B | USA |
 |
Nevro Corp.
NVRO
|
-49.11 | - | - | $ 217 M | USA |
 |
Surgalign Holdings
SRGA
|
212.23 | - | -32.98 % | $ 1.68 M | USA |
 |
STRATA Skin Sciences
SSKN
|
-25.42 | - | - | $ 6.6 M | USA |